Dataset Information

Resource implications of preparing individual participant data from a clinical trial to share with external researchers.

ABSTRACT: Demands are increasingly being made for clinical trialists to actively share individual participant data (IPD) collected from clinical trials using responsible methods that protect the confidentiality and privacy of clinical trial participants. Clinical trialists, particularly those receiving public funding, are often concerned about the additional time and money that data-sharing activities will require, but few published empirical data are available to help inform these decisions. We sought to evaluate the activity and resources required to prepare anonymised IPD from a clinical trial in anticipation of a future data-sharing request.Data from two UK publicly funded clinical trials were used for this exercise: 2437 participants with epilepsy recruited from 90 hospital outpatient clinics in the SANAD trial and 146 children with neuro-developmental problems recruited from 18 hospitals in the MENDS trial. We calculated the time and resources required to prepare each anonymised dataset and assemble a data pack ready for sharing.The older SANAD trial (published 2007) required 50 hours of staff time with a total estimated associated cost of £3185 whilst the more recently completed MENDS trial (published 2012) required 39.5 hours of staff time with total estimated associated cost of £2540.Clinical trial researchers, funders and sponsors should consider appropriate resourcing and allow reasonable time for preparing IPD ready for subsequent sharing. This process would be most efficient if prospectively built into the standard operational design and conduct of a clinical trial. Further empirical examples exploring the resource requirements in other settings is recommended.SANAD: International Standard Randomised Controlled Trials Registry: ISRCTN38354748 . Registered on 25 April 2003.EU Clinical Trials Register Eudract 2006-004025-28 . Registered on 16 May 2007. International Standard Randomised Controlled Trials Registry: ISRCTN05534585 /MREC 07/MRE08/43. Registered on 26 January 2007.

SUBMITTER: Tudur Smith C

PROVIDER: S-EPMC5512949 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Resource implications of preparing individual participant data from a clinical trial to share with external researchers.

Tudur Smith Catrin C Nevitt Sarah S Appelbe Duncan D Appleton Richard R Dixon Pete P Harrison Janet J Marson Anthony A Williamson Paula P Tremain Elizabeth E

Trials 20170717 1

<h4>Background</h4>Demands are increasingly being made for clinical trialists to actively share individual participant data (IPD) collected from clinical trials using responsible methods that protect the confidentiality and privacy of clinical trial participants. Clinical trialists, particularly those receiving public funding, are often concerned about the additional time and money that data-sharing activities will require, but few published empirical data are available to help inform these deci ...[more]

PMID: 28712359

Similar Datasets

Project description:BACKGROUND:Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity. Early identification of women at risk during pregnancy is required to plan management. Although there are many published prediction models for pre-eclampsia, few have been validated in external data. Our objective was to externally validate published prediction models for pre-eclampsia using individual participant data (IPD) from UK studies, to evaluate whether any of the models can accurately predict the condition when used within the UK healthcare setting. METHODS:IPD from 11 UK cohort studies (217,415 pregnant women) within the International Prediction of Pregnancy Complications (IPPIC) pre-eclampsia network contributed to external validation of published prediction models, identified by systematic review. Cohorts that measured all predictor variables in at least one of the identified models and reported pre-eclampsia as an outcome were included for validation. We reported the model predictive performance as discrimination (C-statistic), calibration (calibration plots, calibration slope, calibration-in-the-large), and net benefit. Performance measures were estimated separately in each available study and then, where possible, combined across studies in a random-effects meta-analysis. RESULTS:Of 131 published models, 67 provided the full model equation and 24 could be validated in 11 UK cohorts. Most of the models showed modest discrimination with summary C-statistics between 0.6 and 0.7. The calibration of the predicted compared to observed risk was generally poor for most models with observed calibration slopes less than 1, indicating that predictions were generally too extreme, although confidence intervals were wide. There was large between-study heterogeneity in each model's calibration-in-the-large, suggesting poor calibration of the predicted overall risk across populations. In a subset of models, the net benefit of using the models to inform clinical decisions appeared small and limited to probability thresholds between 5 and 7%. CONCLUSIONS:The evaluated models had modest predictive performance, with key limitations such as poor calibration (likely due to overfitting in the original development datasets), substantial heterogeneity, and small net benefit across settings. The evidence to support the use of these prediction models for pre-eclampsia in clinical decision-making is limited. Any models that we could not validate should be examined in terms of their predictive performance, net benefit, and heterogeneity across multiple UK settings before consideration for use in practice. TRIAL REGISTRATION:PROSPERO ID: CRD42015029349 .

Project description:ObjectiveTo evaluate the performance of a UK based prediction model for estimating fat-free mass (and indirectly fat mass) in children and adolescents in non-UK settings.DesignIndividual participant data meta-analysis.Setting19 countries.Participants5693 children and adolescents (49.7% boys) aged 4 to 15 years with complete data on the predictors included in the UK based model (weight, height, age, sex, and ethnicity) and on the independently assessed outcome measure (fat-free mass determined by deuterium dilution assessment).Main outcome measuresThe outcome of the UK based prediction model was natural log transformed fat-free mass (lnFFM). Predictive performance statistics of R2, calibration slope, calibration-in-the-large, and root mean square error were assessed in each of the 19 countries and then pooled through random effects meta-analysis. Calibration plots were also derived for each country, including flexible calibration curves.ResultsThe model showed good predictive ability in non-UK populations of children and adolescents, providing R2 values of >75% in all countries and >90% in 11 of the 19 countries, and with good calibration (ie, agreement) of observed and predicted values. Root mean square error values (on fat-free mass scale) were <4 kg in 17 of the 19 settings. Pooled values (95% confidence intervals) of R2, calibration slope, and calibration-in-the-large were 88.7% (85.9% to 91.4%), 0.98 (0.97 to 1.00), and 0.01 (-0.02 to 0.04), respectively. Heterogeneity was evident in the R2 and calibration-in-the-large values across settings, but not in the calibration slope. Model performance did not vary markedly between boys and girls, age, ethnicity, and national income groups. To further improve the accuracy of the predictions, the model equation was recalibrated for the intercept in each setting so that country specific equations are available for future use.ConclusionThe UK based prediction model, which is based on readily available measures, provides predictions of childhood fat-free mass, and hence fat mass, in a range of non-UK settings that explain a large proportion of the variability in observed fat-free mass, and exhibit good calibration performance, especially after recalibration of the intercept for each population. The model demonstrates good generalisability in both low-middle income and high income populations of healthy children and adolescents aged 4-15 years.

Project description:BACKGROUND:E-science technologies have significantly increased the availability of data. Research grant providers such as the European Union increasingly require open access publishing of research results and data. However, despite its significance to research, the adoption rate of open data technology remains low across all disciplines, especially in Europe where research has primarily focused on technical solutions (such as Zenodo or the Open Science Framework) or considered only parts of the issue. METHODS AND FINDINGS:In this study, we emphasized the non-technical factors perceived value and uncertainty factors in the context of academia, which impact researchers' acceptance of open data-the idea that researchers should not only publish their findings in the form of articles or reports, but also share the corresponding raw data sets. We present the results of a broad quantitative analysis including N = 995 researchers from 13 large to medium-sized universities in Germany. In order to test 11 hypotheses regarding researchers' intentions to share their data, as well as detect any hierarchical or disciplinary differences, we employed a structured equation model (SEM) following the partial least squares (PLS) modeling approach. CONCLUSIONS:Grounded in the value-based theory, this article proclaims that most individuals in academia embrace open data when the perceived advantages outweigh the disadvantages. Furthermore, uncertainty factors impact the perceived value (consisting of the perceived advantages and disadvantages) of sharing research data. We found that researchers' assumptions about effort required during the data preparation process were diminished by awareness of e-science technologies (such as Zenodo or the Open Science Framework), which also increased their tendency to perceive personal benefits via data exchange. Uncertainty factors seem to influence the intention to share data. Effects differ between disciplines and hierarchical levels.

Dataset Information

Resource implications of preparing individual participant data from a clinical trial to share with external researchers.

Publications

Resource implications of preparing individual participant data from a clinical trial to share with external researchers.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets